Skip to main content
Equibles
ECIA logo

ECIA · Encision Inc · Metrics

Track ECIA — free

Use ECIA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ECIA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.01 -0.03 (-72.09%) At close · Sep 30
Rebalance outlook locked
Going-concern doubt — flagged Nov 13, 2025

Substantial doubt about the company's ability to continue as a going concern.

“As such, there is substantial doubt about the Company's ability to continue as a going concern.”
View the 10-Q filed Nov 13, 2025
Customer concentration — key customers 11% of receivables

Key customers — 11% of receivables (September 30, 2025)

“The accounts receivable balance at September 30, 2025, of $761,947 and at March 31, 2025, of $786,471 included no more than 11% from any one customer.”
View the 10-Q filed Nov 13, 2025
Market Cap
$194,115
Shares
16.88M
Volume · Sep 30 26.47K Avg daily vol (17 sessions) 10.1K

ECIA metrics

65 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$0.01
Market cap
$194,115

Price action

20 metrics
Price change (1W)
-72.0%
Price change (30D)
—
Price change (3M)
—
Price change (6M)
-91.2%
Price change (YTD)
-91.8%
Price change (1Y)
-97.0%
Trailing year
Price change (5Y)
—
52-week high
$0.39
52-week low
$0.00
Change from 52-week high
-97.0%
Change from 52-week low
+5,650.0%
Annualized volatility
4,001.7%
Annualized volatility (3M)
—
Beta
—
RSI (14D)
42.7
Price vs SMA 50
-89.2%
Price vs SMA 200
-96.0%
Avg volume (3M)
—
Relative volume
—
Average dollar volume
—

Company

3 metrics
Sector
Healthcare
Industry
Medical Instruments & Supplies
Shares outstanding
16.88M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
0.1×
reciprocal yield 1,792.0%
EV / EBITDA
—
EV / EBIT
—
P / sales
0.0×
reciprocal yield 3,245.4%
P / book
0.1
reciprocal yield 960.7%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-196.2%

Historical valuation

8 metrics
P / E historical average (3Y)
23.4×
reciprocal yield 4.3%
P / E historical average (5Y)
23.4×
reciprocal yield 4.3%
EV / revenue historical average (3Y)
0.7×
reciprocal yield 143.8%
EV / revenue historical average (5Y)
0.9×
reciprocal yield 109.5%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
—

Profitability

9 metrics
Gross margin
52.6%
Operating margin
-5.1%
Trailing 12 months
Net margin
-6.0%
Gross profit (TTM)
$3.32M
Operating profit (TTM)
−$319,676
Net income (TTM)
−$380,943
Trailing 12 months
Diluted EPS (TTM)
$-0.03
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$0.51
Gross profit per diluted share (TTM)
$0.27
Operating profit per diluted share (TTM)
$-0.02
EBITDA per diluted share (TTM)
$-0.02
Net income per diluted share (TTM)
$-0.03
Operating cash flow per diluted share (TTM)
$-0.04
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
$0.05
Stock compensation per diluted share (TTM)
$0.00
Book value per share
$0.14

Growth

11 metrics
Revenue growth YoY
-13.0%
Year over year
Net income growth YoY
—
Revenue (TTM)
$6.30M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+19.5%
Year over year · more shares
Revenue CAGR (3Y)
-5.1%
Revenue CAGR (5Y)
-3.1%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-20.4%
Return on assets
-9.4%
Debt / equity
0.1
Current ratio
2.3
EBITDA (TTM)
−$232,238
Free cash flow (TTM)
—
Quick ratio
0.9
Interest coverage
-5.7
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$157,426
Latest balance sheet
Cash & equivalents
$71,731
Total assets
$4.06M
Total debt
$229,157

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$489,796
Capital expenditures (TTM)
$55,071
R&D (TTM)
$665,289
SG&A (TTM)
—
Stock compensation (TTM)
$43,641
R&D / revenue
10.6%
Stock compensation / revenue
0.7%

Ownership (13F)

9 metrics
13F filers
—
13F filer change QoQ
—
Institutional ownership
—
Conviction holders (share of 13F filers)
—
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
—
Holder tenure
—
Price vs estimated holder cost
—

Ownership (registered funds)

1 metrics
Index-fund ownership
0.0%

Short interest

3 metrics
Short interest
—
Latest settlement
Days to cover
—
Short-squeeze score
—

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
Flagged
Key facts CIK 930775 CUSIP 29254Q104 Visit website Investor relations